Tuesday November 24 2009 | Biotechnology feed | All feeds
|
|
Macrozyme B.V.
Download detailed PDF Members: Macrozyme was founded in 2001 based on patented technologies of the Academic Medical Center, Amsterdam. The company focuses on the development of new proprietary compounds for the treatment of diabetes, inflammatory disorders and lysosomal storage diseases. These compounds were discovered by Prof. Dr. Hans Aerts and his group.The research activities of Macrozyme are outsourced to several academic groups. These research activities concentrate on the role of glycolipid metabolism in various diseases.
This page has been viewed 277 times since April 2007, the link to the organisation's website has been followed 61 times Recent Search Terms used to find this page: macrozyme | MacroZyme | MacroZyme B.V. | macrozyme bv | macrozyme amsterdam | macrozyme amsterdam | Macrozyme B.V. | macrozyme amsterdam | Macrozyme B.V. | . Search for more companies in Amsterdam This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Macrozyme B.V. | |||||||||||||||||||||||||||||||||||||||||
|